Thermo Fisher Scientific (TMO) Change in Account Payables (2009 - 2020)

Thermo Fisher Scientific (TMO) has reported Change in Account Payables for 12 consecutive years, with $279.0 million the latest figure, recorded in Q4 2020.

• For the quarter ending Q4 2020, Change in Account Payables rose 42.35% year-over-year to $279.0 million; the trailing twelve-month figure through Dec 2020 stood at $59.0 million (down 77.82% YoY), and the FY2025 full-year result was $421.0 million, up 98.58% from the prior year.
• Change in Account Payables advanced to $279.0 million in Q4 2020 per TMO's latest filing, from $277.0 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $279.0 million in Q4 2020 and bottomed at -$256.0 million in Q2 2020.
• Historically, Change in Account Payables has averaged $42.8 million across 5 years, with a median of $15.6 million in 2016.
• The widest YoY moves for Change in Account Payables: up 2812.87% in 2017, down 1374.51% in 2017.
• Over 5 years, Change in Account Payables stood at -$10.1 million in 2016, then surged by 2812.87% to $274.0 million in 2017, then decreased by 10.22% to $246.0 million in 2018, then declined by 20.33% to $196.0 million in 2019, then soared by 42.35% to $279.0 million in 2020.
• According to Business Quant data, Change in Account Payables over the past three periods registered $279.0 million, $277.0 million, and -$256.0 million for Q4 2020, Q3 2020, and Q2 2020 respectively.